Your browser doesn't support javascript.
loading
Mepolizumab effectiveness and identification of super-responders in severe asthma.
Harvey, Erin S; Langton, David; Katelaris, Constance; Stevens, Sean; Farah, Claude S; Gillman, Andrew; Harrington, John; Hew, Mark; Kritikos, Vicky; Radhakrishna, Naghmeh; Bardin, Philip; Peters, Matthew; Reynolds, Paul N; Upham, John W; Baraket, Melissa; Bowler, Simon; Bowden, Jeffrey; Chien, Jimmy; Chung, Li Ping; Grainge, Christopher; Jenkins, Christine; Katsoulotos, Gregory P; Lee, Joy; McDonald, Vanessa M; Reddel, Helen K; Rimmer, Janet; Wark, Peter A B; Gibson, Peter G.
Afiliação
  • Harvey ES; Centre of Excellence in Severe Asthma and Priority Research Centre for Healthy Lungs, Faculty of Health, University of Newcastle, Newcastle, Australia.
  • Langton D; Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia.
  • Katelaris C; Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
  • Stevens S; Dept of Thoracic Medicine, Frankston Hospital, Frankston, Australia.
  • Farah CS; School of Medicine, Western Sydney University, Campbelltown, Australia.
  • Gillman A; Immunology and Allergy Unit, Campbelltown Hospital, Campbelltown, Australia.
  • Harrington J; Centre of Excellence in Severe Asthma and Priority Research Centre for Healthy Lungs, Faculty of Health, University of Newcastle, Newcastle, Australia.
  • Hew M; Dept of Thoracic Medicine, Concord Hospital, Concord, Australia.
  • Kritikos V; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Australia.
  • Radhakrishna N; Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia.
  • Bardin P; Allergy, Asthma and Clinical Immunology, Alfred Health, Melbourne, Australia.
  • Peters M; Dept of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, Australia.
  • Reynolds PN; Respiratory Dept, St Vincent's Hospital, Melbourne, Australia.
  • Upham JW; Lung and Sleep Medicine, Monash University and Medical Centre, Clayton, Australia.
  • Baraket M; Dept of Thoracic Medicine, Concord Hospital, Concord, Australia.
  • Bowler S; Lung Research, Hanson Institute and Dept of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia.
  • Bowden J; Dept of Respiratory Medicine, Princess Alexandra Hospital, Woolloongabba, Australia.
  • Chien J; The University of Queensland Diamantina Institute, Woolloongabba, Australia.
  • Chung LP; South Western Sydney Clinical School, University of New South Wales, Sydney, Australia.
  • Grainge C; Ingham Institute for Applied Medical Research, Sydney, Australia.
  • Jenkins C; Dept of Respiratory Medicine, Mater Hospital Brisbane, South Brisbane, Australia.
  • Katsoulotos GP; Respiratory and Sleep Services, Flinders Medical Centre and Flinders University, Bedford Park, Australia.
  • Lee J; Dept of Sleep and Respiratory Medicine, Westmead Hospital, Westmead, Australia.
  • McDonald VM; School of Medicine, The University of Sydney, Sydney, Australia.
  • Reddel HK; Dept of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Australia.
  • Rimmer J; Dept of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, Australia.
  • Wark PAB; Dept of Thoracic Medicine, Concord Hospital, Concord, Australia.
  • Gibson PG; Concord Clinical School University of Sydney, Concord, Australia.
Eur Respir J ; 55(5)2020 05.
Article em En | MEDLINE | ID: mdl-32139455
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Eosinófilos / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Eur Respir J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos / Eosinófilos / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Oceania Idioma: En Revista: Eur Respir J Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália